Gene therapy for ALS: A review is a research paper published in Molecular Therapy (2021). On theSindex it has a DataRank of 0.780. It has been cited 180 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.780
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institute of Neurological Disorders and Stroke
Grant: NS09435
National Institute of Neurological Disorders and Stroke
Grant: NS111671
National Institute of Neurological Disorders and Stroke
Grant: NS114106
NIH HHS
Grant: S10 OD012006
NINDS NIH HHS
Grant: U01 NS111671
NINDS NIH HHS
Grant: K08 NS114106
NINDS NIH HHS
Grant: F32 NS009435
National Institutes of Health
Grant: 5K08NS114106-05
Viral-based Therapeutic Approaches for Reversal of ALS Pathology
CHEO Research Institute
Sächsische Aufbaubank
FWCI
13.61
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals